ALS ASX: The laboratory testing group writes down $258m drug stake, buys remainder for nothing
The laboratory testing group says it will be able to run the European pharmaceuticals business better once it owns the entire group.
Stay updated with breaking news from Bar Securities. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The laboratory testing group says it will be able to run the European pharmaceuticals business better once it owns the entire group.
Citing the Commonwealth budget impact, the regulator is looking at why some subsidised players – like those with high debt – have big costs.
The move is blamed on higher costs including labour and rent, but arrives ahead of the Albanese government’s new childcare subsidies beginning July.
Shares fell in the Brisbane-based laboratory giant, even as profits jumped.
What will happen as the ACCC reviews price regulations for the childcare sector, and the federal government introduces shock controls for gas pricing?